Home/Filings/4/0001104659-20-097591
4//SEC Filing

Cavan John T 4

Accession 0001104659-20-097591

CIK 0001583771other

Filed

Aug 20, 8:00 PM ET

Accepted

Aug 21, 4:15 PM ET

Size

5.3 KB

Accession

0001104659-20-097591

Insider Transaction Report

Form 4
Period: 2020-08-19
Cavan John T
Chief Financial Officer
Transactions
  • Award

    Stock Options

    2020-08-19+160,000381,060 total
    Exercise: $3.72Exp: 2030-08-19Common Stock (160,000 underlying)
Footnotes (1)
  • [F1]53,333 of the stock options vest on 8/19/2021 and the remainder vests monthly in equal amounts over 24 months.

Documents

1 file

Issuer

Hepion Pharmaceuticals, Inc.

CIK 0001583771

Entity typeother

Related Parties

1
  • filerCIK 0001503738

Filing Metadata

Form type
4
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 4:15 PM ET
Size
5.3 KB